Diagnostic screening programs help catch cancer, abnormalities or other diseases before they reach an advanced stage, saving lives and healthcare costs. Screening programs include, lung, breast, prostate, and cervical cancer, among many others.
New findings support the routine use of deep learning-based risk assessments, as this method can decrease subjectivity, reduce unnecessary imaging and improve diagnostic accuracy.
The COlorectal Cancer detection with AI, or COCA, model is a cost-effective, scalable solution that turns routine CT scans into opportunistic exams that can be used to proactively identify CRC.
Two respected radiology organizations have issued a stark warning on the new recommendations, stating that they risk confusing patients and “may contribute to thousands of additional breast cancer deaths each year.”
It is estimated that less than 20% of eligible patients in the U.S. adhere to LCS recommendations, despite numerous studies highlighting the exam’s effectiveness.
Chest X-rays could be the key to mitigating the issue of overdiagnosis in certain patient populations undergoing lung cancer screening, according to new research.
Reducing false positives could decrease the frequency of unnecessary procedures, lower the associated costs and also ease patient anxiety concerning CT results.